NCT01519947View on ClinicalTrials.gov

A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 30, 2012

Primary Completion Date

May 30, 2015

Study Completion Date

May 30, 2015

Conditions

Anemia, Kidney Disease, Chronic

Interventions

DRUG

Methoxy polyethylene glycol-epoetin beta

Participants received 50-250 mcg SC according to local label

Trial Locations (7)

20210

Clínica San Cosme Centro Especializado en el Tratamiento de Enfermedades Renales S.C, Aguascalientes

21100

Centro de hemodialisis del norte S.C., Mexicali

48333

Unidad De Dialisis La Loma S.C., Pureto Vallarta

58070

Hospital Star Medica Morelia, Morelia

91700

Hospital Regional De Alta Especialidad De Veracruz; Nephrology, Veracruz

CP. 04700

Nefros Investigación S.C., Delegación Coyoacan

07760

Hospital Angeles Lindavista;Nefrologia, Mexico City

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01519947 - A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis | Biotech Hunter | Biotech Hunter